Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer

BACKGROUND: Prolonged infusion of low dose gemcitabine (PLDG) in combination with platinum has shown promising activity in terms of improved response rate and progression free survival (PFS); especially in squamous non-small cell lung cancer (NSCLC). Hence, we conducted a phase 3 randomized non-infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Patil, Vijay, Noronha, Vanita, Joshi, Amit, Chougule, Anuradha, Kannan, Sadhana, Bhattacharjee, Atanu, Goud, Supriya, More, Sucheta, Chandrasekharan, Arun, Menon, Nandini, Srinivas, Sujay, Vallathol, Dilip Harindran, Dsouza, Hollis, Majumdar, Swaratika, Das, Sudeep, Zawar, Abhinav, Khaddar, Satvik, Kumar, Amit, Singh, Gunjesh, Kumar, Kanteti Aditya Pavan, Ravind, Rahul, Trivedi, Vaishakhi, Behel, Vichitra, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510888/
https://www.ncbi.nlm.nih.gov/pubmed/31143878
http://dx.doi.org/10.1016/j.eclinm.2019.03.011

Ejemplares similares

Ejemplares similares